[Do the new drugs improve therapeutic strategies for stage IV NSCLC?].
Depierre
A
A
Service de Pneumologie, CHU de Besançon, 3, boulevard A. Fleming, 25030 Besançon.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging
D000970:Antineoplastic Agents